We are live on ! Find out more
CRVO icon

CervoMed

10 hedge funds and large institutions have $2.51M invested in CervoMed in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,799% more capital inflows, than outflows

Capital inflows: $2.8M | Capital outflows: $96.4K

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

25% more funds holding

Funds holding: 8 → 10 (+2)

9.16% more ownership

Funds ownership: 1.24% → 10.41% (+9.2%)

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

CRVO Hedge Fund Activity: Q2 2017 in Review

10 of the 4,024 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2017, worth a combined $2.51M — up 389% from $513K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CRVO positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Swift Run Capital Management, opening a new position worth an estimated $1.98M. The largest seller was Goldman Sachs, exiting entirely with an estimated $61K sold.

  • 10 institutional investors held CervoMed (CRVO) as of Q2 2017, up from 8 in Q1 2017.
  • Funds reported $2.51M of CervoMed stock for Q2 2017, up 389% quarter-over-quarter.
  • 4 funds opened new CervoMed positions in Q2 2017 and 2 closed out, a net change of +2 holders.
  • The largest CervoMed buyer in Q2 2017 was Swift Run Capital Management, an estimated $1.98M added.
  • The largest CervoMed seller in Q2 2017 was Goldman Sachs, an estimated $61K sold.

Based on aggregated 13F filings for Q2 2017.